CHEOY

Cochlear Limited

OTC Markets OTCPKUSDEQUITY DELAYED

48.51

▲ 0.24 (0.50%)

MARKET · —

Price

Open

48.30

Prev close

48.27

Day high

48.51

Day low

48.30

Volume

1.11K

Market cap

—

P/E (TTM)

—

52W range

31.82 – 104.65

Options chain

Account required

ExpirySpot 48.51

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Trailing performance

Price return · vs SPY

Returnvs SPY

+3.59% +5.0%

+24.90% +21.2%

+39.40% +36.3%

-30.69% -41.8%

YTD

-43.87% -56.2%

-49.35% -69.4%

-39.62% -113.8%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Financial statements

As reported · 5 years · 1 quarters

Blank means not reported, not zero

Line item	2026	2025	2024	2023	2022	YoY
Total revenue	$2.35B	$2.34B	$2.24B	$1.94B	—	+0.2%
Operating revenue	$2.35B	$2.34B	$2.24B	$1.94B	—	+0.2%
Cost of revenue	$688.00M	$615.20M	$562.10M	$488.00M	—	+11.8%
Gross profit	$1.66B	$1.73B	$1.67B	$1.45B	—	-4.0%
Research & development	$323.20M	$291.50M	$277.00M	$244.90M	—	+10.9%
Selling, general & admin	$1.02B	$939.90M	$897.60M	$810.40M	—	+8.8%
Total operating expense	$1.45B	$1.32B	$1.26B	$1.14B	—	+9.7%
Operating income	$209.20M	$406.10M	$414.00M	$311.90M	—	-48.5%
Net interest income	-$3.00M	$700.00K	$9.80M	$7.10M	—	-528.6%
Pre-tax income	$213.90M	$518.50M	$484.80M	$396.60M	—	-58.7%
Tax provision	$66.60M	$129.60M	$128.00M	$96.00M	—	-48.6%
Net income	$147.30M	$388.90M	$356.80M	$300.60M	—	-62.1%
Net income to common	$147.30M	$388.90M	$356.80M	$300.60M	—	-62.1%
Basic EPS	—	2.97	2.72	2.29	2.20	—
Diluted EPS	—	2.97	2.72	2.28	2.20	—
EBIT	$227.10M	$529.50M	$494.00M	$406.00M	—	-57.1%
EBITDA	$331.80M	$619.90M	$578.90M	$486.90M	—	-46.5%
Basic shares	—	130.88M	131.07M	131.52M	131.54M	—
Diluted shares	—	130.88M	131.42M	131.81M	131.54M	—

Line item

2026

2025

2024

2023

2022

YoY

Total revenue

$2.35B

$2.34B

$2.24B

$1.94B

—

+0.2%

Operating revenue

$2.35B

$2.34B

$2.24B

$1.94B

—

+0.2%

Cost of revenue

$688.00M

$615.20M

$562.10M

$488.00M

—

+11.8%

Gross profit

$1.66B

$1.73B

$1.67B

$1.45B

—

-4.0%

Research & development

$323.20M

$291.50M

$277.00M

$244.90M

—

+10.9%

Selling, general & admin

$1.02B

$939.90M

$897.60M

$810.40M

—

+8.8%

Total operating expense

$1.45B

$1.32B

$1.26B

$1.14B

—

+9.7%

Operating income

$209.20M

$406.10M

$414.00M

$311.90M

—

-48.5%

Net interest income

-$3.00M

$700.00K

$9.80M

$7.10M

—

-528.6%

Pre-tax income

$213.90M

$518.50M

$484.80M

$396.60M

—

-58.7%

Tax provision

$66.60M

$129.60M

$128.00M

$96.00M

—

-48.6%

Net income

$147.30M

$388.90M

$356.80M

$300.60M

—

-62.1%

Net income to common

$147.30M

$388.90M

$356.80M

$300.60M

—

-62.1%

Basic EPS

—

2.97

2.72

2.29

2.20

—

Diluted EPS

—

2.97

2.72

2.28

2.20

—

EBIT

$227.10M

$529.50M

$494.00M

$406.00M

—

-57.1%

EBITDA

$331.80M

$619.90M

$578.90M

$486.90M

—

-46.5%

Basic shares

—

130.88M

131.07M

131.52M

131.54M

—

Diluted shares

—

130.88M

131.42M

131.81M

131.54M

—

Line item	2026	2025	2024	2023	2022	YoY
Cash & equivalents	$187.70M	$275.70M	$513.60M	$555.50M	—	-31.9%
Cash & short-term investments	$187.70M	$275.70M	$513.60M	$555.50M	—	-31.9%
Accounts receivable	$507.00M	$533.80M	$425.30M	$388.40M	—	-5.0%
Inventory	$491.30M	$499.40M	$391.60M	$311.50M	—	-1.6%
Total current assets	$1.30B	$1.42B	$1.45B	$1.36B	—	-8.2%
Property, plant & equipment	$525.00M	$536.20M	$517.20M	$447.20M	—	-2.1%
Goodwill & intangibles	$483.20M	$500.80M	$451.00M	$444.10M	—	-3.5%
Total assets	$2.60B	$2.83B	$2.75B	$2.57B	—	-7.9%
Total current liabilities	$604.50M	$602.30M	$631.50M	$578.00M	—	+0.4%
Current debt	—	—	—	—	$42.60M	—
Total debt	$212.70M	$235.70M	$243.70M	$201.80M	—	-9.8%
Total liabilities	$862.40M	$874.70M	$904.60M	$819.90M	—	-1.4%
Retained earnings	$645.70M	$777.30M	$667.90M	$555.40M	—	-16.9%
Shareholder equity	$1.74B	$1.95B	$1.84B	$1.75B	—	-10.8%
Working capital	$695.70M	$814.50M	$820.60M	$783.50M	—	-14.6%
Net tangible assets	$1.26B	$1.45B	$1.39B	$1.30B	—	-13.3%
Shares issued	65.40M	65.40M	65.49M	65.67M	—	+0.0%

Line item

2026

2025

2024

2023

2022

YoY

Cash & equivalents

$187.70M

$275.70M

$513.60M

$555.50M

—

-31.9%

Cash & short-term investments

$187.70M

$275.70M

$513.60M

$555.50M

—

-31.9%

Accounts receivable

$507.00M

$533.80M

$425.30M

$388.40M

—

-5.0%

Inventory

$491.30M

$499.40M

$391.60M

$311.50M

—

-1.6%

Total current assets

$1.30B

$1.42B

$1.45B

$1.36B

—

-8.2%

Property, plant & equipment

$525.00M

$536.20M

$517.20M

$447.20M

—

-2.1%

Goodwill & intangibles

$483.20M

$500.80M

$451.00M

$444.10M

—

-3.5%

Total assets

$2.60B

$2.83B

$2.75B

$2.57B

—

-7.9%

Total current liabilities

$604.50M

$602.30M

$631.50M

$578.00M

—

+0.4%

Current debt

—

$42.60M

—

Total debt

$212.70M

$235.70M

$243.70M

$201.80M

—

-9.8%

Total liabilities

$862.40M

$874.70M

$904.60M

$819.90M

—

-1.4%

Retained earnings

$645.70M

$777.30M

$667.90M

$555.40M

—

-16.9%

Shareholder equity

$1.74B

$1.95B

$1.84B

$1.75B

—

-10.8%

Working capital

$695.70M

$814.50M

$820.60M

$783.50M

—

-14.6%

Net tangible assets

$1.26B

$1.45B

$1.39B

$1.30B

—

-13.3%

Shares issued

65.40M

65.49M

65.67M

—

+0.0%

Line item	2026	2025	2024	2023	YoY
Capital expenditure	-$90.70M	-$102.60M	-$89.80M	-$95.90M	+11.6%
Investing cash flow	-$104.50M	-$115.20M	-$105.70M	-$125.70M	+9.3%
Share buybacks	-$100.00K	-$28.30M	-$43.00M	-$29.60M	+99.6%
Dividends paid	-$281.20M	-$278.20M	-$245.70M	-$197.40M	-1.1%
Financing cash flow	-$344.00M	-$366.90M	-$323.80M	-$310.40M	+6.2%
Free cash flow	$277.30M	$135.00M	$299.00M	$266.50M	+105.4%
End cash position	$187.70M	$275.70M	$513.60M	$555.50M	-31.9%

Line item

2026

2025

2024

2023

YoY

Capital expenditure

-$90.70M

-$102.60M

-$89.80M

-$95.90M

+11.6%

Investing cash flow

-$104.50M

-$115.20M

-$105.70M

-$125.70M

+9.3%

Share buybacks

-$100.00K

-$28.30M

-$43.00M

-$29.60M

+99.6%

Dividends paid

-$281.20M

-$278.20M

-$245.70M

-$197.40M

-1.1%

Financing cash flow

-$344.00M

-$366.90M

-$323.80M

-$310.40M

+6.2%

Free cash flow

$277.30M

$135.00M

$299.00M

$266.50M

+105.4%

End cash position

$187.70M

$275.70M

$513.60M

$555.50M

-31.9%

Line item	2025-06-30	YoY
Cash & equivalents	$275.70M
Cash & short-term investments	$275.70M
Accounts receivable	$533.80M
Inventory	$499.40M
Total current assets	$1.42B
Property, plant & equipment	$536.20M
Goodwill & intangibles	$500.80M
Total assets	$2.83B
Total current liabilities	$602.30M
Total debt	$235.70M
Total liabilities	$874.70M
Retained earnings	$777.30M
Shareholder equity	$1.95B
Working capital	$814.50M
Net tangible assets	$1.45B
Shares issued	65.40M

Line item

2025-06-30

YoY

Cash & equivalents

$275.70M

Cash & short-term investments

$275.70M

Accounts receivable

$533.80M

Inventory

$499.40M

Total current assets

$1.42B

Property, plant & equipment

$536.20M

Goodwill & intangibles

$500.80M

Total assets

$2.83B

Total current liabilities

$602.30M

Total debt

$235.70M

Total liabilities

$874.70M

Retained earnings

$777.30M

Shareholder equity

$1.95B

Working capital

$814.50M

Net tangible assets

$1.45B

Shares issued

65.40M

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

47.30

+2.55% from price

SMA 20

44.97

+7.87% from price

SMA 50

42.46

+14.25% from price

SMA 100

42.65

+13.75% from price

SMA 200

62.26

-22.09% from price

EMA 12

46.88

+3.47% from price

EMA 26

44.94

+7.93% from price

EMA 50

43.79

+10.79% from price

RSI (14)

66.9

Neutral

MACD (12,26,9)

1.94

Hist 0.36

ATR (14)

1.14

2.35% of price

Realised vol 30D

39.0%

Annualised

Bollinger upper

50.40

20, 2σ

Bollinger lower

39.54

20, 2σ

50 / 200 cross

Death

42.46 vs 62.26

Trend bias

Below 200

-22.09%

Risk profile

Daily returns · 1Y window

Beta vs SPY

0.57

Less volatile than market

Correlation to SPY

0.14

Largely independent

Realised vol 30D

39.0%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-68.7%

Peak to trough

Max drawdown 5Y

-72.4%

Peak to trough

ATR 14

1.14

2.35% of price

Beta (reported)

—

5Y monthly, from filing

Headlines

CHEOY · links out to the publisher

Health Care Roundup: Market Talk The Wall Street Journal · 4d ago Cochlear Ltd (CHEOF) (FY 2026) Earnings Call Highlights: Navigating Market Headwinds with Nexa ... GuruFocus.com · 5d ago Cochlear introduces the new Osia® 3 Sound Processor PR Newswire · 41d ago Don't Miss the Moments That Matter This Summer: Hearing Experts and Cochlear Encourage People to Check Their Hearing Health PR Newswire · 57d ago [Latest] Global Ear Health Market Size/Share Worth USD 16.87 Billion by 2035 at a 5.7% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) GlobeNewswire · 66d ago Better Hearing and Whole-Body Health: What to Know About MRI Access with Cochlear Implants PR Newswire · 85d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.